Neurogene Inc.
NGNE
$15.22
-$0.29-1.87%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.84% | -918.88% | -38.69% | -55.92% | -37.98% |
| Total Depreciation and Amortization | -7.64% | -3.62% | -2.54% | -0.73% | 0.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 111.30% | 113.28% | 131.59% | 385.58% | 163.80% |
| Change in Net Operating Assets | 79.05% | 78.91% | 57.53% | -175.65% | -163.32% |
| Cash from Operations | 4.05% | -3.09% | -34.54% | -70.40% | -59.72% |
| Capital Expenditure | -1,100.00% | 9.38% | -103.66% | -460.98% | -124.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -247.55% | -2,150.00% | -- | -- | -- |
| Cash from Investing | -250.48% | -497.27% | -35,224.39% | -28,697.56% | 103,324.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -36.36% | -62.50% | -20.00% | -166.67% | -120.00% |
| Issuance of Common Stock | -96.98% | 19,007,700.00% | 308.57% | 1,975.00% | 461.61% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | 100.00% | 100.00% | -- |
| Cash from Financing | 100.06% | 101.56% | 107.14% | 563.95% | -6,197.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3,837.37% | -32.19% | -229.22% | -311.88% | 113.07% |